期刊文献+

^18F-FDG PET融合CT对胸中段食管鳞癌区域淋巴结分期的前瞻性研究 被引量:1

Prospective clinical research of ^18SF-fluorodeoxy-glucose PET combined CT in detecting district lymph node clinical stage of middle thoracic squamous cell esophageal carcinoma
原文传递
导出
摘要 目的 探讨正电子发射型电子计算机断层(PET)显像在胸中段食管鳞癌患者术前区域淋巴结临床分期中的应用价值。方法 30例行现代二野淋巴结清扫术的胸中段食管鳞癌患者,术前进行全身^18F-氟代脱氧葡萄糖(^18F-FDG)PET融合CT显像与CT显像,对区域淋巴结检查结果进行对照研究。结果 现代二野淋巴结清扫术后发现24例患者区域淋巴结阳性(80.00%),转移区域淋巴结总数为61枚。^18F-FDG PET融合CT发现食管区域淋巴结转移16例,敏感性、特异性和Youden指数分别为66.67%、100.0%和0.67。CT检出8例。61枚转移区域淋巴结中^18F-FDG PET融合CT定性43枚(70.49%),定量分析发现转移区域淋巴结计算标准化摄取值(SUV)为2.9±1.2,均〉2.5;CT检出区域淋巴结转移数24枚(39.34%)。^18F-FDG PET融合CT在区域淋巴结转移患者与区域淋巴结转移数均明显优于CT,P〈0.05。结论 ^18F-FDG PET融合CT在诊断胸中段食管鳞癌区域淋巴结转移方面可能优于CT。 Objective To evaluate the role of ^18F-FDG PET for district lymph node diagnose and clinical stage of middle thoracic squamous cell esophageal carcinoma. Methods 30 patients with squamous cell esophageal carcinoma in middle thoracic had modern two-field lymph node dissection. They underwent whole body ^18F-FDG PET combined CT imaging and CT imaging before operation. They were contrasted with the examination result of district lymph node. Results 24 patients (80. 00% ) in postopemtion of modern two-field lymph node dissection were found to be positive in district lymph node. The total number of metastatic district lymph nodes was 61. 16 of them were detected by ^18 F- FDG PET combined CT, the sensitivity, specificity and Youden index of ^18F-FDG PET combined CT were 66. 67% ,100. 0% ,0. 67 ,respectively. 8 of them were detected by CT. 43(70.49% ) lymph nodes were identified metastases in 61 by ^18F-FDG PET combined CT, and 24 (39. 34% ) by CT. The result of quantitative analysis showed metastatic district lymph node changed SUV as 2. 9±1.2,all 〉2. 5.^18F-FDG PET combined CT was more sensitive than CT in the patient and the number of metastatic district lymph nodes, P 〈0. 05. Conclusion ^18F-FDG PET combined CT is superior to CT in detecting district esophagus lymph node metastasis.
出处 《国际肿瘤学杂志》 CAS 2007年第1期75-77,共3页 Journal of International Oncology
关键词 食管肿瘤 体层摄影术 发射型计算机 脱氧葡萄糖 淋巴结转移 Esophagus neoplasms Tomography, ermission computed Deoxyglucos Lymphatic metastasis
  • 相关文献

参考文献16

  • 1Watanabe H,Kato H,Tachimori Y.Significance of extended systemic lymph node dissection for thoracic esophageal carcinoma in Japan.Recent Results Cancer Res,2000,155:123-133.
  • 2Udagawa H,Akiyama H.Surgical treatment of esophageal cancer:Tokyo experience of the three-field technique.Dis Esophagus,2001,14 (2):110-114.
  • 3Kakegawa T.The history of surgical treatment for esophageal carcinoma in the 20th century in Japan.Nippon Geka Gakkai Zasshi,2000,101(12):847-854.
  • 4Igaki H,Kato H,Tachimori Y,et al.Cervical lymph node metastasis in patients with submucosal carcinoma of the thoracic esophagus.J Surg Oncol,2000,75 (1):37-41.
  • 5Hokamura N,Konishi T.Current trends in surgical treatment of esophageal cancer.Gan To Kagaku Ryoho,2000,27(7):967-973.
  • 6Boyle MJ,Franceschl D,Livingsrone AS.Transhiatal versus transthoracic esophagectomy:complication and survival rates.Am Surg,1999,65(12):1137-1141.
  • 7Chandawatkar RY,Kakegawa T,Fujita H,et al.Comparative analysis of imaging modalities in the preoperative assessment of nodal metastasis in esophageal cancer.J Surg Oncol,1996,61 (3):214-217.
  • 8Rice TW.Clinical staging of esophageal carcinoma.CT,EUS,and PET.Chest Surg Clin N Am,2000,10 (3):471-485.
  • 9von Rahden BH,Stein HJ.Staging and treatment of advanced esophageal cancer.Curr Opin Gastroenterol,2005,21 (4):472-477.
  • 10Liberale G,Van Laethem JL,Gay F,et al.The role of PET scan in the preoperative management of oesophageal cancer.Eur J Surg Oncol,2004,30(9):942-947.

二级参考文献23

  • 1Rankin SC, Taylor H, Cook GJ, et al. Computed tomography and positron emission tomography in the pre-operative staging of oesophageal carcinoma. Chin Radiol,1998, 53(9) :659-655.
  • 2Kole AC,Plukker JT, Nieweg OE, et al. Positron emission tomography for staging of oesophageal and gastroesophageal malignancy. Br J Cancer, 1998,78 (4) :521-527.
  • 3Kneist W,Schreckenberger M, Bartenstein P, et al. Positron emission tomography for staging of esophageal cancer: does it lead to a different therapeutic approach? World J Surg ,2003,27 ( 10 ): 1105-1112.
  • 4McAteer D,Wallis F,Couper G, et al. Evaluation of 18F-FDG positron emission tomography in gastric and oesophageal carcinoma. Br J Radiol, 1999,72 ( 858 ) :525-529.
  • 5Kato H, Kuwano H, Nakajima M, et al. Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma . Cancer, 2002, 15,94 ( 4 ): 921 -928.
  • 6Himeno S, Yasuda S, Shimada H, et al. Evaluation of esophageal cancer by positron emission tomography. Jpn J Clin Oncol, 2002,32 (9):340-346.
  • 7Menzel Ch,Dobert N,Rieker O,et al. 18F-Deoxyglucose PET for the staging of oesophageal cancer: influence of histopathological subtype and tumour grading. Nuklearmedizin ,2003,42( 3 ) :90-93.
  • 8Kato H,Takita J,Miyazaki T, et al. Correlation of 18-F-fluorodeoxyglucose(FDG) accumulation with glucose transporter (Glut-1) expression in esophageal squamous cell carcinoma . Anticancer Res,2003,23 (4) :3263-3272.
  • 9Stahl A, Ott K, Weber WA, et al. FDG PET imaging of locally advanced gastric carcinomas: correlation with endoscopic and histopathological findings. EurJ Nucl Med Mol Imaging,2003,30(2):288-295.
  • 10Kawamura T, Kusakabe T, Sugino T, et al. Expression of glucose transporter-1 in human gastric carcinoma Association with tumour aggressiveness, metastasis, and patient survival. Cancer, 2001,92(3) :634-641.

共引文献1

同被引文献12

  • 1郭洪波,于金明,张百江,朱慧,黄勇,付政.^(18)FDG PET-CT检测进展期食管癌淋巴结转移的临床价值[J].中华放射肿瘤学杂志,2006,15(4):290-295. 被引量:17
  • 2袁双虎,于金明,于甬华,杨新华,付政,杨国仁,郭洪波,王晓航,周英智,陈少卿.^(18)F-脱氧葡萄糖PET-CT检测食管癌病变长度的临床价值[J].中华放射肿瘤学杂志,2006,15(5):389-392. 被引量:46
  • 3向作林,吴铮,曾昭冲,刘建军,华逢春,陈刚,王健.^(18)F-脱氧葡萄糖PET/CT诊断复发性食管癌的价值[J].中国癌症杂志,2006,16(11):976-979. 被引量:4
  • 4Kamel EM,Thumshirn M,Truninger K,et al.Significance of incidental 18F-FDG accumulations in the gastrointestinal tract in PET/CT:correlation with endoscopic and histopathologic results.J Nucl Med,2004,45(11):1804-1810.
  • 5Bruzzi JF,Munden RF,Troung MT,et al.PET/CT of esophageal cancer:its role in clinical management.Radiographics,2007,27(6):1635-1652.
  • 6Larson SM,Schoder H,Yeung H.Positron emission tomography/computerized tomography functional imaging of esophageal and colorectal cancer.Cancer J,2004,10(4):243-250.
  • 7Mamede M,El Fakhri G,Abreu-e-Lima P,et al.Pre-operative estimation of esophageal tumor metabolic length in FDG-PET images with surgical pathology confirmation.Ann Nucl Med,2007,21 (10):553-562.
  • 8Roedl JB,Colen RR,King K,et al.Visual PET/CT scoring for nonspecific 18F-FDG uptake in the differentiation of early malignant and benign esophageal lesions.AJR Am J Roentgenol,2008,191(2):515-521.
  • 9Schreurs LM,Pultrum BB,Koopmans KP,et al.Better assessment of nodal metastases by PET/CT fusion compared to side-by-side PET/CT in esophageal cancer.Anticancer Res,2008,28(3B):1867-1873.
  • 10Kato H,Kuwano H,Nakajima M,et al.Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma.Cancer,2002,94(4):921-928.

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部